Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02555982 : Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor
PhasePhase 3
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- Patients suffering from a head tremor without (isolated) or with associated

- tremor in any other body parts.

- The HT must be troublesome for the patients (TRS 2 for the head tremor

- severity item).

- Patients never treated with botulinum toxin.

- Men or women aged from 18 to 80 years old.

- Social security coverage.

- Ability to provide informed consent.

Exclusion Criteria:

- Patients with tremor from cerebellar syndrome (multiple sclerosis, etc.).

- Patients with a predominant dystonic jerky or myoclonic head tremor using

- the Tsui scale (>1).

- Oral treatments for HT are allowed but must be stable during the study.

- Any contra-indication to Botulinum toxin.

- Women without efficient contraception.

- Patients under supervision or (legal) guardianship.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02555982      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740